Literature DB >> 34381297

Increasing Pediatric Audiology Services via Telehealth.

Tommy Evans1, Timothy Nejman1, Erin Stewart1, Ian Windmill1.   

Abstract

Telehealth as a means to deliver health care services has been used by physicians for many years, but the use of telehealth in audiology, specifically in pediatrics, has been minimal. Barriers such as licensure, reimbursement, technology, and equipment have been cited as reasons for audiologists not participating in telehealth. However, the COVID-19 pandemic created the need for telehealth services to be widely used to safely increase access to healthcare, and emergent orders helped reduce previous barriers so that audiologists could participate in telehealth service delivery. This article details three cases where audiologists delivered telehealth services to children. These case studies demonstrate portions of the Division of Audiology Telehealth Program of the Cincinnati Children's Hospital Medical Center and how they increased access to hearing healthcare in response to the COVID-19 pandemic. Thieme. All rights reserved.

Entities:  

Keywords:  audiology; auditory processing disorders; hearing aids; pandemic; pediatrics; telehealth

Year:  2021        PMID: 34381297      PMCID: PMC8328539          DOI: 10.1055/s-0041-1731694

Source DB:  PubMed          Journal:  Semin Hear        ISSN: 0734-0451


  2 in total

1.  Stories From the Webcams: Cincinnati Children's Hospital Medical Center Audiology Telehealth and Pediatric Auditory Device Services.

Authors:  Wendy Steuerwald; Ian Windmill; Michael Scott; Thomas Evans; Kathleen Kramer
Journal:  Am J Audiol       Date:  2018-11-19       Impact factor: 1.493

2.  Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020.

Authors:  Mark É Czeisler; Kristy Marynak; Kristie E N Clarke; Zainab Salah; Iju Shakya; JoAnn M Thierry; Nida Ali; Hannah McMillan; Joshua F Wiley; Matthew D Weaver; Charles A Czeisler; Shantha M W Rajaratnam; Mark E Howard
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-11       Impact factor: 17.586

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.